These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34750017)

  • 1. Cholesterol - the devil you know; ceramide - the devil you don't.
    Tippetts TS; Holland WL; Summers SA
    Trends Pharmacol Sci; 2021 Dec; 42(12):1082-1095. PubMed ID: 34750017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. You aren't IMMUNE to the ceramides that accumulate in cardiometabolic disease.
    Varre JV; Holland WL; Summers SA
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jun; 1867(6):159125. PubMed ID: 35218934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification.
    Hilvo M; Vasile VC; Donato LJ; Hurme R; Laaksonen R
    Front Endocrinol (Lausanne); 2020; 11():570628. PubMed ID: 33133018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide Metabolism in Cardiovascular Disease: A Network With High Therapeutic Potential.
    Zietzer A; Düsing P; Reese L; Nickenig G; Jansen F
    Arterioscler Thromb Vasc Biol; 2022 Oct; 42(10):1220-1228. PubMed ID: 36004640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceramides improve atherosclerotic cardiovascular disease risk assessment beyond standard risk factors.
    Meeusen JW; Donato LJ; Kopecky SL; Vasile VC; Jaffe AS; Laaksonen R
    Clin Chim Acta; 2020 Dec; 511():138-142. PubMed ID: 33058843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): implications for lipid raft structure and function.
    Megha ; London E
    J Biol Chem; 2004 Mar; 279(11):9997-10004. PubMed ID: 14699154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceramides and other sphingolipids as drivers of cardiovascular disease.
    Choi RH; Tatum SM; Symons JD; Summers SA; Holland WL
    Nat Rev Cardiol; 2021 Oct; 18(10):701-711. PubMed ID: 33772258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studies.
    McGurk KA; Keavney BD; Nicolaou A
    Atherosclerosis; 2021 Jun; 327():18-30. PubMed ID: 34004484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceramide Biomarkers Predictive of Cardiovascular Disease Risk Increase in Healthy Older Adults After Bed Rest.
    Petrocelli JJ; McKenzie AI; Mahmassani ZS; Reidy PT; Stoddard GJ; Poss AM; Holland WL; Summers SA; Drummond MJ
    J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(9):1663-1670. PubMed ID: 32215553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could Ceramides Become the New Cholesterol?
    Summers SA
    Cell Metab; 2018 Feb; 27(2):276-280. PubMed ID: 29307517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceramides - Lipotoxic Inducers of Metabolic Disorders.
    Chaurasia B; Summers SA
    Trends Endocrinol Metab; 2015 Oct; 26(10):538-550. PubMed ID: 26412155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DES1: A Key Driver of Lipotoxicity in Metabolic Disease.
    Blitzer JT; Wang L; Summers SA
    DNA Cell Biol; 2020 May; 39(5):733-737. PubMed ID: 32181687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sterol affinity for bilayer membranes is affected by their ceramide content and the ceramide chain length.
    Nyholm TK; Grandell PM; Westerlund B; Slotte JP
    Biochim Biophys Acta; 2010 May; 1798(5):1008-13. PubMed ID: 20044977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease.
    Nicholson RJ; Pezzolesi MG; Summers SA
    Front Endocrinol (Lausanne); 2020; 11():622692. PubMed ID: 33584550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in plasma triglycerides and ceramides: links with cardiac function in humans with type 2 diabetes.
    Peterson LR; Jiang X; Chen L; Goldberg AC; Farmer MS; Ory DS; Schaffer JE
    J Lipid Res; 2020 Jul; 61(7):1065-1074. PubMed ID: 32393551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramides as Mediators of Oxidative Stress and Inflammation in Cardiometabolic Disease.
    Gaggini M; Ndreu R; Michelucci E; Rocchiccioli S; Vassalle C
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio.
    Heneghan HM; Huang H; Kashyap SR; Gornik HL; McCullough AJ; Schauer PR; Brethauer SA; Kirwan JP; Kasumov T
    Surg Obes Relat Dis; 2013; 9(1):100-7. PubMed ID: 22264909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Ceramides in the Molecular Pathogenesis and Potential Therapeutic Strategies of Cardiometabolic Diseases: What we Know so Far.
    Shalaby YM; Al Aidaros A; Valappil A; Ali BR; Akawi N
    Front Cell Dev Biol; 2021; 9():816301. PubMed ID: 35127726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiology.
    Wittenbecher C; Cuadrat R; Johnston L; Eichelmann F; Jäger S; Kuxhaus O; Prada M; Del Greco M F; Hicks AA; Hoffman P; Krumsiek J; Hu FB; Schulze MB
    Nat Commun; 2022 Feb; 13(1):936. PubMed ID: 35177612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase behavior of aqueous dispersions of mixtures of N-palmitoyl ceramide and cholesterol: a lipid system with ceramide-cholesterol crystalline lamellar phases.
    Souza SL; Capitán MJ; Alvarez J; Funari SS; Lameiro MH; Melo E
    J Phys Chem B; 2009 Feb; 113(5):1367-75. PubMed ID: 19133760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.